a list of 1415 rare diseases that are related to EMMA strains. Please use the search bar to search for rare diseases, gene name, ORPHAcode or EMMA strain.
View this resource Bookmark this resourceRare Disease
Rare Diseases: Natural
History Studies for
Drug Development Guidance for Industry
Published by FDA
Natural HistoryRare DiseaseThis guidance is intended to help inform the design and implementation of natural history studies that can be used to support the development of safe and effective drugs and biological products
for rare diseases. Although the focus of this guidance is rare diseases; the recommendations in the guidance may be applicable to drug development for nonrare diseases.
Private funding
Published by IRDiRC
AwardCrowdfundingFoundations or DonationsLoanPrivateRare DiseaseVenture Capital or Angel InvesmentList of different kinds of private funding available for orphan drug development.
View this resource Bookmark this resourceMultiple websites/platforms provide crowd funding services or describes how to initiate crowdfunding for rare diseases
View this resource Bookmark this resource
FDA Expedited Program for serious conditions – Fast Track Designation
Published by IRDiRC
Early Access SupportExpedited ProgrammeFast Track DesignationRare DiseaseRegulatory AdviceRegulatory AffairsProcess designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need.
View this resource Bookmark this resource
Alternative designs for Small Population Clinical Trials
Published by IRDiRC
Adaptative PathwaysClinical DevelopmentClinical TrialClinical Trial DesignRare DiseaseRegulatory SciencesSmall PopulationGuidance and general recommendations are available to select the most efficient study design for each medical condition or trial, and on potential adaptions of conventional designs to the low sample size scenario.
View this resource Bookmark this resource
NCATS Toolkit for Patients-Focused Therapy Development
Published by IRDiRC
NCATS ToolkitPatient-FocusRare DiseaseResearch and Drug DevelopmentTherapy DevelopmentToolkit for PatientThe NCATS Toolkit for Patient-Focused Therapy Development (Toolkit) was developed through a collaboration between NCATS and rare diseases patient groups. The patient groups had expressed an interest in exchanging knowledge and sharing best practices in therapy development
View this resource Bookmark this resource
Orphanet database
Published by IRDiRC
DatabaseDatabase or Tool OrphanetOrphan DrugRare DiseaseResearch and Drug DevelopmentOrphanet is a unique public resource worldwide, gathering and improving knowledge on all rare diseases (RD), affecting less than 1 in 2’000 people in the European population.
View this resource Bookmark this resource
New-born screening programs
Published by IRDiRC
Genetic ConditionNewborn Sreening ProgrammePatient InformationRare DiseaseResearch and Drug DevelopmentThe purpose of NBS is to detect potentially fatal or disabling conditions in newborns as early as possible and possibly before onset of symptoms. Such detection allows the early treatment which may significantly modify the natural history of the disease and potentially prevent developmental delays, physical disabilities and eventually death.
View this resource Bookmark this resource
FAIR principle for data use
Published by IRDiRC
FAIRGuidelinePatient RegistryRare DiseaseResearch and Drug DevelopmentLack of ultimate data use in rare disease created many silos slowing down development. The FAIR is coming to bridge this gap by proving essential guidelines for optimal data use.
View this resource Bookmark this resource
